Cyclacel Pharmaceuticals, Inc. (BGMS)
NASDAQ
Cyclacel Pharmaceuticals, Inc. PS Ratio 2006–2026
Current and historical P/S ratio for Cyclacel Pharmaceuticals, Inc. (BGMS): market cap divided by trailing twelve-month revenue. As of March 31, 2026 it is 3.58.
From: 09/30/2025To: 03/31/2026
Stock Price
TTM Revenue
PS Ratio
Cyclacel Pharmaceuticals, Inc. PS Ratio — FAQ
Cyclacel Pharmaceuticals, Inc. (BGMS) ps ratio over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BGMS's ps ratio history?
The chart and table above show Cyclacel Pharmaceuticals, Inc.'s ps ratio by year and by quarter, including the growth rate.